SLC25A22 Activators are a diverse set of chemical compounds that, through various mechanisms, enhance the activity of the mitochondrial glutamate carrier SLC25A22. Compounds like Cyclosporin A work by maintaining mitochondrial membrane potential via inhibition of the mPTP, facilitating the electrochemical conditions necessary for SLC25A22's glutamate transport function. Protonophores such as CCCP disrupt the mitochondrial membrane potential, which could indirectly lead to an adaptive increase in SLC25A22 activity to restore ionic balance. Similarly, the mitochondrial health optimizers, Coenzyme Q10 and Alpha-Lipoic Acid, as well as the alternative electron carrier Methylene Blue, contribute to the optimal functioning of the electron transport chain, thus indirectly enhancing the SLC25A22 carrier activity by ensuring an efficient electrochemical gradient. The role of Leucine in activating the mTOR pathway also suggests a potential for increased SLC25A22 activity, as enhanced protein synthesis may include upregulation of mitochondrial transporters.
Moreover, NADH, as a key electron donor in the mitochondrial respiratory chain, potentially boosts the activity of SLC25A22 by increasing the demand for glutamate transport in response to heightened metabolic activity. Retinoic Acid, by modulating gene expression, may upregulate mitochondrial carriers, including SLC25A22, to meet altered cellular requirements. The involvement of Zinc in glutamate metabolism hints at a regulatory role that could encompass the enhancement of SLC25A22 function, possibly by modifying intracellular signaling related to glutamate use. Lastly, Creatine's critical contribution to cellular energy pools suggests that its presence may necessitate an increase in SLC25A22-mediated glutamate transport to support the high-energy demands associated with creatine phosphate turnover in mitochondria.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressant that inhibits mitochondrial permeability transition pore (mPTP). Inhibition of mPTP can maintain mitochondrial membrane potential, which may indirectly enhance SLC25A22 activity by stabilizing the electrochemical gradient necessary for glutamate transport. | ||||||
Carbonyl Cyanide m-Chlorophenylhydrazone | 555-60-2 | sc-202984A sc-202984 sc-202984B | 100 mg 250 mg 500 mg | $77.00 $153.00 $240.00 | 8 | |
CCCP is another protonophore that collapses the proton gradient across the mitochondrial membrane, potentially leading to an upregulation of SLC25A22 activity in an attempt to restore the gradient. | ||||||
Coenzyme Q10 | 303-98-0 | sc-205262 sc-205262A | 1 g 5 g | $71.00 $184.00 | 1 | |
Coenzyme Q10 is involved in the mitochondrial electron transport chain, where it accepts electrons and is reduced to ubiquinol. By optimizing electron transport chain efficiency, it may indirectly enhance SLC25A22 function by maintaining the electrochemical gradient. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
As a primary electron donor in the electron transport chain, an increase in NADH can boost mitochondrial activity, which may enhance SLC25A22's glutamate transport function to meet the increased metabolic demand. | ||||||
Methylene blue | 61-73-4 | sc-215381B sc-215381 sc-215381A | 25 g 100 g 500 g | $43.00 $104.00 $328.00 | 3 | |
Methylene Blue acts as an alternative electron carrier in the mitochondrial electron transport chain, which could support enhanced mitochondrial function and indirectly increase SLC25A22 activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid influences gene expression and has been shown to affect mitochondrial function. While not a direct activator, it could lead to an upregulation of mitochondrial carriers like SLC25A22 by altering gene expression profiles. | ||||||
α-Lipoic Acid | 1077-28-7 | sc-202032 sc-202032A sc-202032B sc-202032C sc-202032D | 5 g 10 g 250 g 500 g 1 kg | $69.00 $122.00 $212.00 $380.00 $716.00 | 3 | |
Alpha-Lipoic Acid is known for its role in mitochondrial bioenergetics. It can potentially enhance the function of SLC25A22 by improving overall mitochondrial function and the electrochemical gradient. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $62.00 | ||
Leucine is an amino acid that can activate the mammalian target of rapamycin (mTOR) pathway, which is involved in protein synthesis and may indirectly upregulate SLC25A22 to meet cellular metabolic demands. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions have a regulatory role in synaptic transmission and could influence glutamate metabolism. Through its interaction with glutamate metabolism, zinc may indirectly enhance the activity of SLC25A22. | ||||||
Creatine, anhydrous | 57-00-1 | sc-214774 sc-214774A | 10 mg 50 g | $28.00 $79.00 | 2 | |
Creatine plays a role in maintaining cellular energy pools. Supplementation could lead to an increased demand for glutamate transport via SLC25A22 to maintain the creatine phosphate pool in mitochondria. | ||||||